pharma consulting Archives - DelveInsight

pharma consulting

pharma-consultant
Reliable Experts in Pharmacology Market: Pharma Consultants

In the new fast-paced world, with unlimited access to information and technology, it gets overwhelming for various companies, be it an established goliath or a new start-up, to take important deci...


Pharma news fro GSK, InCarda, BridgeBio
GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; B...

GSK eyes robust immune response from RSV vaccineCold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear...


Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; Abbott's MitraClip4; Grail Buyback
Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 ...

Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca Samsung Biologics announced the conclusion of a long-term supply deal with AstraZeneca worth USD 330.8 Million. ...


Pharma News
Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million.More than decade old Life Sciences-based investment firm special...


pharma news
Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion.Under the terms of the agreement, Merck will pay USD 20 for each share in cash for a total amount of US...


Pharma News
EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achill...

EicOsis has received USD 15Million grant from the National Institute of Drug Abuse (NIDA) to fund the clinical trials of non-opioid pain therapy.NIDA, with an aim to supplement NIH’s initiati...


Pharma News
EU approval for Imbruvica; Pharming licenses orphan drug

EU recommends the use of Imbruvica for two new indicationsThe Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission (EC). Ibrutinib i...


transthyretin amyloidosis
Notizia

Arming antibiotics with a vaccination-like immune responseHarnessing the ability of the body’s immune system has already well-tried to be effective in treating cancer. Marcos Pires, Ph.D., a Le...



Default Blog Image
NF-κB Inhibitors- A Promising Future

NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a protein transcription factor that can orchestrate complex biological processes such as cell survival, cytokine production...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.